✦ LIBER ✦

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

✍ Scribed by Ilfet Songun; Hein Putter; Elma Meershoek-Klein Kranenbarg; Mitsuru Sasako; Cornelis JH van de Velde

Book ID: 117785328
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 612 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70070-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgical treatment of gastric cancer: 15

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

✍ Ilfet Songun; Hein Putter; Elma Meershoek-Klein Kranenbarg; Mitsuru Sasako; Corn 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 612 KB

Background Historical data and recent studies show that standardised extended (D2) lymphadenectomy leads to better results than standardised limited (D1) lymphadenectomy. Based on these findings, the Dutch D1D2 trial, a nationwide prospectively randomised clinical trial, was undertaken to compare D2

46LBA 15-years follow-up results of the

46LBA 15-years follow-up results of the randomized Dutch D1D2 Trial: lower cancer-related mortality after D2

✍ I. Songun; H. Putter; E. Meershoek-Klein Kranenbarg; C.J.H. van de Velde 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Postoperative morbidity and mortality af

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

✍ A Cuschieri; V Joypaul; P Fayers; P Cook; J Fielding; J Craven; J Bancewicz 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 600 KB

Patient survival after D1 and D2 resecti

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

✍ Cuschieri, A; Weeden, S; Fielding, J; Bancewicz, J; Craven, J; Joypaul, V; Sydes 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Morbidity and mortality after D1 and D2

Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial

✍ M Degiuli; M Sasako; M Calgaro; M Garino; F Rebecchi; M Mineccia; D Scaglione; D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Treatment with trastuzumab for 1 year af

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB